BusinessNews brief

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

NewsJaws News FeedSource-attributed news briefs
1 min read
The Australian flag above Parliament House in Canberra
File photograph: The Australian flag above Parliament House in Canberra. Marcus Reubenstein / Unsplash. Illustrative context, not a photograph of this reported event.
LinkedInPostEmail
Save for later

Australia's Telix Pharmaceuticals said on Monday it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis.

Read the original report at Reuters.

Read in depth: Business

The Shark Tank business reached Starbucks and attracted a corporate buyer. SEC filings explain the later shutdown—and why the purchase price was never the founders’...

5 min read

The business grew through local franchise operators, restaurants and shipping. Here is how to find the food today—and how to read the founders’ latest book announcement.

4 min read

Sources and context

Reuters

Source headline and summary supplied via NewsData.io. First collected by NewsJaws on 2026-09-21. This is an automated news brief, not original NewsJaws reporting. Dates reflect the source publication. Feed delays may apply.

More from Business